相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome
Stefan Zeuzem et al.
JOURNAL OF HEPATOLOGY (2017)
Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir
David Wyles et al.
JOURNAL OF HEPATOLOGY (2017)
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
Christoph Sarrazin et al.
GASTROENTEROLOGY (2016)
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Jean-Michel Pawlotsky
GASTROENTEROLOGY (2016)
Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment
Sabrina Bagaglio et al.
VIRUSES-BASEL (2016)
Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents
Prabhav Kalaghatgi et al.
PLOS ONE (2016)
Global prevalence of pre-existing HCV variants resistant to directacting antiviral agents (DAAs): mining the GenBank HCV genome data
Zhi-wei Chen et al.
SCIENTIFIC REPORTS (2016)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
RESISTANCE ANALYSIS OF VIROLOGIC FAILURES IN HEPATITIS C GENOTYPE 1 INFECTED PATIENTS TREATED WITH GRAZOPREVIR/ELBASVIR plus /- RIBAVIRIN: THE C-WORTHY STUDY
S. Black et al.
JOURNAL OF HEPATOLOGY (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
G. R. Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
Julia Dietz et al.
PLOS ONE (2015)
Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden
Ida Lindstrom et al.
INFECTIOUS DISEASES (2015)
Update on hepatitis C virus resistance to direct-acting antiviral agents
Eva Poveda et al.
ANTIVIRAL RESEARCH (2014)
Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naive patients
Stefania Paolucci et al.
VIROLOGY JOURNAL (2013)
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor
Zulema Plaza et al.
ANTIVIRAL THERAPY (2012)
分享论文
